Vendor, Palo Alto, CA
4J Therapeutics Inc.
UEI SZCGV7LQJKR4, CAGE 9DFF0
1 award and $14,894,558 obligated between August 21, 2026 and August 21, 2026, 100% under full and open competition, against 1.0 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $14,894,558 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $14,894,558 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50124C00052Definitive Contract, August 21, 2026, Full and Open Competition, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | The Purpose of This Modification Is to Update Article B.3 Estimated Cost-Plus Fixed Fee Clins, Establish Clins 3A (Option Period 2A) and CliNAICS 541714, PSC AN13 | $14,894,558 |
- Places of performance
- California
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 1 across 1 awards